ASAM Clinical Considerations: Buprenorphine Treatment of Opioid Use Disorder for Individuals Using High-potency Synthetic Opioids.

Weimer, Melissa B; Herring, Andrew A; Kawasaki, Sarah S; Meyer, Marjorie; Kleykamp, Bethea A; Ramsey, Kelly S

Weimer, Melissa B; Herring, Andrew A; Kawasaki, Sarah S; Meyer, Marjorie; Kleykamp, Bethea A; Ramsey, Kelly S.

Afiliação

Weimer MB; From the Yale School of Medicine, Program in Addiction Medicine, New Haven, CT (MBW); Yale School of Public Health, New Haven, CT (MBW); Division of Addiction Medicine, Highland Hospital-Alameda Health System, Oakland, CA (AAH); Department of Psychiatry and Internal Medicine, Penn State Health, Hershey, PA (SSK); University of Vermont, Burlington, VT (MM); BAK and Associates, Baltimore, MD (BAK); NYS Office of Addiction Services and Supports (OASAS), Albany, NY (KSR).

J Addict Med ; 17(6): 632-639, 2023.

Article em En | MEDLINE | ID: mdl-37934520

Assuntos

Buprenorfina; Estimulantes do Sistema Nervoso Central; Transtornos Relacionados ao Uso de Opioides; Humanos; Analgésicos Opioides; Estudos Prospectivos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Buprenorfina / Estimulantes do Sistema Nervoso Central / Transtornos Relacionados ao Uso de Opioides Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google